Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer
Conditions: Recurrent Ovarian Carcinoma Interventions: Drug: Lenvatinib+Toripalimab. Sponsors: Peking Union Medical College Hospital; The Second Affiliated Hospital of Dalian Medical University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
The Correlation Between HRD Detection and the Efficacy of PARP Inhibitors in Ovarian Cancer
Conditions: Ovarian Neoplasms Interventions: Genetic: homologous recombination deficiency Sponsors: Fujian Cancer Hospital; Fujian Provincial Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy
Conditions: Ovarian Cancer Interventions: Procedure: Second Look Laparoscopy Sponsors: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
A Study of MGC026 in Participants With Advanced Solid Tumors
Conditions: Advanced Solid Tumor; Advanced Cancer; Metastatic Cancer; Squamous Cell Carcinoma of Head and Neck; Non Small Cell Lung Cancer; Small-cell Lung Cancer; Bladder Cancer; Sarcoma; Endometrial Cancer; Melanoma; Castration Resistant Prostatic Cancer; Cervical Cancer; Colorectal Cancer; Gastric Cancer; Gastro-esophageal Cancer; Pancreas Cancer; Clear Cell Renal Cell Carcinoma; Hepatocellular Carcinoma; Platinum-resistant Ovarian Cancer Interventions: Biological: MGC026 Dose Escalation; Biological: MGC026 Dose for Expansion Sponsors: MacroGenics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
Conditions: Metastatic Solid Tumor; Recurrent Solid Tumor; Advanced Solid Tumor; Urinary Bladder Neoplasm; Triple Negative Breast Cancer; Non-small Cell Lung Cancer; Esophageal Cancer; Pancreatic Cancer; Ovarian Cancer; Cervical Cancer; Head and Neck Squamous Cell Carcinoma; Prostate Cancer; Renal Pelvis Cancer; Bladder Cancer Interventions: Drug: LY4101174 Sponsors: Eli Lilly and Company; Loxo Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors
Conditions: Neoplasm Malignant Interventions: Biological: STRO-002 Sponsors: Tasly Pharmaceutical Group Co., Ltd; Sutro Biopharma, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Early-stage Ovarian Clear Cell Carcinoma (OCCC) Patients at Risk of Recurrence
Conditions: FIGO Stage IC2 to II Ovarian Clear Cell Carcinoma Sponsors: National Taiwan University Hospital; Chang Gung Memorial Hospital; Tokyo University; Samsung Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China
Conditions: Cervical Cancer; Endometrial Cancer; Ovarian Cancer; HER2 Expression Interventions: Other: no intervention Sponsors: Chongqing University Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Effect of Early Enteral Nutrition on Postoperative Recovery of Ovarian Cancer Patients
Conditions: Advanced Epithelial Ovarian Cancer Interventions: Device: Transnasal jejunal tube; Other: Transvenous access Sponsors: Luo Chengyan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer
Conditions: Solid Tumor, Adult Interventions: Drug: BH009 Sponsors: Zhuhai Beihai Biotech Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Conditions: Ovarian Cancer; Solid Tumor Interventions: Drug: CUSP06 Sponsors: OnCusp Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer
Conditions: Ovarian Cancer Interventions: Diagnostic Test: 68Ga-FAPI-46; Diagnostic Test: 18F-FDG Sponsors: Chang Gung Memorial Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Patients Derived Organoids as a Promising Tool to Tailor Ovarian Cancer Therapies (PANDORA).
Conditions: Ovarian Cancer Sponsors: Centro di Riferimento Oncologico - Aviano Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
SUROVA - Surgery in Ovarian Cancer, Comparing Primary and Interval Cytoreductive Surgery
Conditions: Epithelial Ovarian Cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms Interventions: Procedure: Cytoreductive surgery; Drug: Neoadjuvant chemotherapy; Drug: Adjuvant chemotherapy Sponsors: Clinica Universidad de Navarra, Universidad de Navarra; Asociaci ón de Amigos de la Universidad de Navarra Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution
Conditions: Ovarian Cancer; Radiotherapy Side Effect; Symptom Cluster Interventions: Other: no Intervention Sponsors: Yandi Zhu Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
